Biotek Remedys
BioTek reMEDys is a US specialty pharmacy founded in 2013 that dispenses infusion and specialty medications (IVIG/SCIG, factor therapy, MS, hepatitis, transplant, Huntington's) to patients with rare and chronic conditions, coordinating with physicians, payors, and home infusion nurses nationwide.
- Company typePrivate
- Founded2013
- HeadquartersNew Castle, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Biotek Remedys does
BioTek reMEDys is a US-based specialty pharmacy founded in 2013 that dispenses specialty medications, biologics, and infusion therapies to patients with rare diseases and chronic conditions. Its therapeutic focus spans primary immunodeficiency (IVIG and SCIG therapy), bleeding disorders (factor therapy for hemophilia A, B, C and von Willebrand disease), multiple sclerosis, hepatitis, post-transplant care, and Huntington's disease. The company operates as an integrated infusion therapy provider, bridging managed care organizations, prescribing physicians, and patients through supply chain management, prior authorization handling, specialty drug dispensing, home infusion coordination, and clinical support services.
The technology platform consists of an integrated web portal for end-to-end order tracking, a patient-facing web portal with auto-refill functionality, and a 24/7 National Customer Support Center staffed by clinical personnel including a pharmacist on call. BioTek holds URAC Specialty Pharmacy Accreditation (ID SPP006999, valid through March 1, 2029) and is recognized by the Immunoglobulin Nursing Society (IgNS). It maintains partnerships with the Hemophilia Federation of America, Hemophilia Treatment Centers, manufacturer patient assistance programs, and a nationwide network of home infusion nurses. Physical operations are centered at a New Castle, Delaware headquarters (which also houses an on-site infusion suite) and a Houston, Texas regional office branded Biotek South.
Revenue is generated primarily through reimbursement from managed care organizations, Medicare, Medicaid, and commercial insurance plans for dispensed specialty medications and home infusion services. The go-to-market model is hybrid B2B2C: a sales-led motion driven by physician and prescriber referrals (accepted electronically, by fax, or phone) combined with direct-to-consumer engagement via the voluntary Patient Management Program, a 24/7 helpline, and patient education content including the Carol's Corner blog. The company employs 51-100 staff and serves patients across all US geographies through free scheduled home or clinic delivery.
Biotek Remedys firmographics
Firmographics- Name
- Biotek Remedys
- Legal name
- BioTek reMEDys
- Website
- https://biotekrx.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BioTek reMEDys is a US specialty pharmacy founded in 2013 that dispenses infusion and specialty medications (IVIG/SCIG, factor therapy, MS, hepatitis, transplant, Huntington's) to patients with rare and chronic conditions, coordinating with physicians, payors, and home infusion nurses nationwide.
- Ownership category
- akta.pro rank
Biotek Remedys industry classification
Industry- Product category
- Specialty Pharmacy Services
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
- akta.pro secondary industry
- Biologics & Biosimilars Distributors (HLAIAJAH)
Keywords
Where Biotek Remedys is headquartered
LocationHeadquarters
- HQ city
- New Castle
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Biotek Remedys business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
Revenue model
- Specialty Pharmacy Services: BioTek reMEDys operates as a specialty pharmacy providing high-end specialty pharmaceutical products. They manage drug utilization, coordinate with physicians and manufacturers, and deliver just-in-time pharmacy distribution services. Revenue is generated through reimbursement from managed care organizations, Medicare, and commercial insurance plans for specialty medications and infusion services.
- Bleeding Disorder Program Services: Specialized programs for hemophilia, von Willebrand disease, and other factor deficiencies. Services include PICC & IV access management, joint bleed assessments, patient education, and coordination with hemophilia treatment centers. Covered by Medicare Medical Assistance and major commercial insurance plans.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Biotek Remedys product offering
Product offeringCore offering
BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy and specialty medications for patients with rare diseases and chronic conditions. The company delivers IVIG and SCIG immunoglobulin therapy, factor therapy for bleeding disorders, home infusion nursing services, and disease-specific care programs for hepatitis, multiple sclerosis, transplants, and Huntington's disease. It bridges managed care, physicians, and patients through supply chain management, specialty-trained pharmacists, and an integrated web portal for order tracking.
Product overview
BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy services for patients with rare diseases and chronic conditions. The company operates as a unified specialty pharmacy platform offering IVIG and SCIG immunoglobulin therapies, factor therapy for bleeding disorders, and disease-specific specialty care programs for Hepatitis, Transplants, Multiple Sclerosis, and Huntington's Disease. Services include home infusion delivery, their Patient Management Program (PMP), and an on-site infusion suite. The company bridges managed care, physicians, and patients through supply chain management, specialty pharmacists, and trained infusion nurses.
Differentiator
Problem solved
Functional benefit
Products and services
- IVIG (Intravenous Immunoglobulin) Therapy
- SCIG (Subcutaneous Immunoglobulin) Therapy
- Factor Therapy
- Bleeding Disorders Program
- Patient Management Program (PMP)
- Specialty Pharmacy Services
- Home Infusion Services
- Hepatitis Management
- Transplant Support
- Multiple Sclerosis Management
- Huntington's Disease Management
- Infusion Suite
Quantifiable outcome
- Delivers superior service at a lower cost through supply chain management and technology
- +2 more outcomes
Companies that use Biotek Remedys
Customer profileNamed customers5 records
Segments6 records
Biotek Remedys technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Biotek Remedys partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Hemophilia Federation of America (HFA)coreBioTek reMEDys has partnered with the Hemophilia Federation of America to administer three $1,000 scholarships for individuals impacted by hemophilia or other significant bleeding disorders. Applications are submitted directly to HFA, and BioTek staff do not see applications or have input into the selection process, ensuring impartiality.
- URACcoreURAC provides independent accreditation for BioTek reMEDys specialty pharmacy operations, validating compliance with quality standards for pharmacy benefit management and clinical operations.
- IgNS (Immunoglobulin Nursing Society)minorIgNS logo appears on the company website indicating membership or recognition from the Immunoglobulin Nursing Society, representing nurses specialized in immunoglobulin therapy.
- Home Infusion Provider NetworkcoreBioTek reMEDys coordinates with extensive nurses and nursing networks to deliver experienced infusion nurses in any area of the country. These partnerships enable home infusion services that offer lower cost and convenience compared to hospital-based infusion.
- Patient Assistance ProgramscoreCompany helps patients navigate Manufacturer Assistance Programs and foundations to access medications and reduce out-of-pocket costs. They coordinate access to patient assistance programs for those who qualify.
- Hemophilia Treatment CenterscoreBioTek reMEDys maintains active communication and care coordination with Hemophilia Treatment Centers (HTCs) and healthcare providers to optimize patient outcomes and ensure comprehensive care for bleeding disorder patients.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Biotek Remedys competitors and assessment
Company assessmentDirect peers
- Accredo by Evernorth: Largest US specialty pharmacy, owned by Evernorth (Cigna). Provides specialty medication dispensing, infusion services, and care management programs across rare and chronic conditions — directly comparable to BioTek's offerings.
- PANTHERx Rare Pharmacy: Specialty pharmacy exclusively focused on rare and orphan diseases, providing high-touch dispensing, patient management, and manufacturer distribution services — closest niche competitor to BioTek's rare-disease focus.
- Optum Specialty Pharmacy (BriovaRx): Specialty pharmacy arm of UnitedHealth/Optum, serving patients with complex conditions including hemophilia and immune disorders with national distribution and clinical management — direct competitor.
- US Bioservices (Cencora): Specialty pharmacy owned by Cencora (formerly AmerisourceBergen), distributing specialty medications and providing patient management programs across therapeutic categories — directly comparable specialty pharmacy.
- Soleo Health: Specialty infusion provider delivering home and alternate-site infusion therapies including IVIG and biologics — directly comparable to BioTek's home infusion and immunoglobulin therapy services.
- Nufactor: Specialty infusion pharmacy focused on hemophilia, immune disorders, and rare conditions, providing home infusion nursing and specialty drug distribution — directly comparable mid-size specialty pharmacy.
- CareMed Specialty Pharmacy: Independent specialty pharmacy providing specialty medications, infusion services, and clinical management for chronic and rare conditions — comparable independent specialty pharmacy competitor.
- Prime Therapeutics Specialty Pharmacy: Specialty pharmacy and pharmacy benefit manager owned by a consortium of Blue Cross Blue Shield plans, providing specialty drug distribution and care management — comparable specialty pharmacy peer with payor-aligned business model.
Broad incumbents
- CVS Specialty: Specialty pharmacy arm of CVS Health, offering nationwide specialty medication fulfillment and clinical support integrated with Caremark PBM — broader incumbent with overlapping service lines.
- Walgreens Specialty Pharmacy: Specialty pharmacy services within Walgreens, providing nationwide specialty drug fulfillment and patient support programs integrated with retail footprint — broad incumbent in the same market.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biotek Remedys social profiles
Digital presenceBiotek Remedys compliance and trust
Trust signalCompliance1 record
Biotek Remedys financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biotek Remedys leadership team
Management profileNumber of profiles
Biotek Remedys funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biotek Remedys M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biotek Remedys
What does Biotek Remedys do?
BioTek reMEDys is a specialty pharmacy providing integrated infusion therapy and specialty medications for patients with rare diseases and chronic conditions. The company delivers IVIG and SCIG immunoglobulin therapy, factor therapy for bleeding disorders, home infusion nursing services, and disease-specific care programs for hepatitis, multiple sclerosis, transplants, and Huntington's disease. It bridges managed care, physicians, and patients through supply chain management, specialty-trained pharmacists, and an integrated web portal for order tracking.
Is Biotek Remedys a public or private company?
Biotek Remedys is a private company. It is currently operating.
When was Biotek Remedys founded?
Biotek Remedys was founded in 2013. It employs 51 to 100 people.
Where is Biotek Remedys based?
Biotek Remedys is headquartered in New Castle, United States, in the North America region.
How does Biotek Remedys make money?
Two revenue lines are on record. Specialty Pharmacy Services are the primary driver. The others are bleeding Disorder Program Services.
Who are Biotek Remedys's main competitors?
Direct peers on record are Accredo by Evernorth, PANTHERx Rare Pharmacy, Optum Specialty Pharmacy (BriovaRx), US Bioservices (Cencora), Soleo Health, Nufactor, CareMed Specialty Pharmacy and Prime Therapeutics Specialty Pharmacy. Broad incumbents are CVS Specialty and Walgreens Specialty Pharmacy.
Does Biotek Remedys have an API?
No public API is recorded for Biotek Remedys.
What industry is Biotek Remedys in?
Biotek Remedys's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLAIAJAH, Biologics & Biosimilars Distributors. Its SIC code is 5047.